Upload Prescription

Gabantip AT Tablet

16% OFF
16% OFF

Original price was: ₹262.05.Current price is: ₹220.00.

Gabantip AT Tablet
Salt Composition: Gabapentin (300mg) + Amitriptyline (10mg)
Company: Sun Pharmaceutical Industries Ltd

10.0 tablets in 1 strip

Buy Now
Category:

Description

Gabantip AT Tablet combines Gabapentin, an anticonvulsant and nerve pain reliever, with Amitriptyline, a tricyclic antidepressant. This prescription medicine is primarily used for neuropathic pain and chronic nerve-related disorders. Gabapentin stabilizes nerve activity, while Amitriptyline enhances pain relief and may help improve sleep in patients with chronic pain.

Uses:

  • Management of neuropathic pain (nerve pain)

  • Treatment of diabetic neuropathy and other peripheral neuropathies

  • Supportive therapy for post-herpetic neuralgia

  • Helps improve nerve function and reduce chronic pain

How to Use:

  • Take exactly as prescribed by your doctor.

  • Swallow the tablet whole with water.

  • Usually taken 1–2 times daily, depending on the doctor’s instructions.

  • Maintain a consistent dosing schedule for optimal effectiveness.

Precautions:

  • Use under strict medical supervision.

  • Inform your doctor if you have heart problems, liver or kidney issues, glaucoma, or a history of seizures.

  • May cause drowsiness or dizziness – avoid driving or operating machinery if affected.

  • Pregnant or breastfeeding women should use only if prescribed.

  • Avoid alcohol while taking this medicine.

Possible Side Effects:

  • Drowsiness, dizziness, or fatigue

  • Dry mouth, nausea, or mild gastrointestinal upset

  • Constipation or blurred vision

  • Rare: severe allergic reactions, heart rhythm changes, or mood alterations

Important:

  • Prescription Required – do not self-medicate.

  • Regular follow-up with your doctor is recommended to monitor effectiveness and side effects.

  • Store in a cool, dry place, away from sunlight and out of reach of children.

Leave a Reply

Your email address will not be published. Required fields are marked *